Sarah A. Taylor

4.0k total citations
146 papers, 2.6k citations indexed

About

Sarah A. Taylor is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah A. Taylor has authored 146 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 40 papers in Surgery and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah A. Taylor's work include Pediatric Hepatobiliary Diseases and Treatments (19 papers), Cancer Treatment and Pharmacology (12 papers) and Liver Disease and Transplantation (11 papers). Sarah A. Taylor is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (19 papers), Cancer Treatment and Pharmacology (12 papers) and Liver Disease and Transplantation (11 papers). Sarah A. Taylor collaborates with scholars based in United States, United Kingdom and Canada. Sarah A. Taylor's co-authors include Richard P. Mills, Peter F. Whitington, Richard Price, Robert J. Belt, Saul E. Rivkin, Margaret D. M. Evans, John Crowley, Thomas F. Patton, Larry A. Sternson and A.J. Repta and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Sarah A. Taylor

139 papers receiving 2.5k citations

Peers

Countries citing papers authored by Sarah A. Taylor

Since Specialization

Citations

This map shows the geographic impact of Sarah A. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Taylor more than expected).

Fields of papers citing papers by Sarah A. Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Taylor. The network helps show where Sarah A. Taylor may publish in the future.

Co-authorship network of co-authors of Sarah A. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Taylor. A scholar is included among the top collaborators of Sarah A. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Taylor. Sarah A. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcriptional analysis of murine biliary atresia identifies macrophage heterogeneity and subset-specific macrophage functions 2025 ·Frontiers in Immunology ·(unknown), (unknown), Gaurav Gadhvi, Liang Feng, Colin T. Shearn, (unknown), Joshua B. Wechsler, Carla M. Cuda, Cara L. Mack, Ronald J. Sokol, William J. Janssen, Richard M. Green, Harris Perlman, Deborah R. Winter, Sarah A. Taylor	0
2	Living Donor Liver Transplantation for Young Biliary Atresia Recipients Is Associated With Improved Outcomes in the Modern Era 2025 ·Pediatric Transplantation ·Ioannis A. Ziogas, (unknown), (unknown), Michael Wachs, Amy G. Feldman, Sarah A. Taylor	0
3	Recent advances in the management of pediatric cholestatic liver diseases 2025 ·Journal of Pediatric Gastroenterology and Nutrition ·Krupa R. Mysore, (unknown), (unknown), Rima Fawaz, (unknown), (unknown), Saeed Mohammad, Sarah A. Taylor	3
4	The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions 2024 ·Cancer Cell ·(unknown), (unknown), (unknown), Sheryl Kunning, (unknown), (unknown), Huda I. Atiya, Ayana T. Ruffin, Sarah A. Taylor, T. Rinda Soong, Riyue Bao, Lan Coffman, Tullia C. Bruno	24
5	Self-inflicted lesions in dermatology: The scars of self-harm 2024 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sarah A. Taylor, Katlein França, John Trinidad, Steven R. Feldman	2
6	Branch and central retinal vein occlusion: clinical pearls from trials of ranibizumab 2017 ·Investigative Ophthalmology & Visual Science ·Mimi Liu, David Eichenbaum, Sarah A. Taylor, (unknown), Carlos Quezada-Ruiz	1
7	Polypoid Endometriosis Presenting as a Colonic Mass 2017 ·ACG Case Reports Journal ·(unknown), Xin Li, Rohit Bhargava, Sarah A. Taylor, Kenneth Lee, Dhiraj Yadav	2
8	Adhesion of epoxy to hydrotalcite conversion coatings: I. Correlation with wettability and electrokinetic measurements 2002 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·(unknown), Sarah A. Taylor, S. R. Taylor, (unknown), (unknown)	22
9	Causes Of Non-Compliance With Drug Regimens In Glaucoma Patients: A Qualitative Study 2002 ·Journal of Ocular Pharmacology and Therapeutics ·Sarah A. Taylor, (unknown), Richard P. Mills	181
10	Adhesion of epoxy to hydrotalcite conversion coatings: II. Surface modification with ionic surfactants 2002 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·(unknown), Sarah A. Taylor, S. R. Taylor, (unknown), (unknown)	31
11	Polymer design for corneal epithelial tissue adhesion: Pore density 2002 ·Journal of Biomedical Materials Research Part A ·Margaret D. M. Evans, Sarah A. Taylor, B. A. Dalton, Dieter Lohmann	20
12	Long‐term stability of a coronary stent coating post‐implantation 2002 ·Journal of Biomedical Materials Research ·Andrew L. Lewis, (unknown), (unknown), J. David Robertson, (unknown), Sarah A. Taylor, Donald R. Ricci	40
13	‘Neo-FAC’ (5-Fluorouracil, Doxorubicin, and Cyclophosphamide) for Poor-Prognosis Stage IV Breast Cancer 1999 ·American Journal of Clinical Oncology ·Georgiana K. Ellis, Stephanie Green, Robert B. Livingston, Michael Kraut, H. Irving Pierce, Jorge C. Paradelo, Sarah A. Taylor, Silvana Martino	1
14	Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck 1993 ·Investigational New Drugs ·Sarah A. Taylor, Jacqueline Benedetti, David Schuller, Stephen P. Richman, G. O. Broun, Alexander Hantel	2
15	Nephropathies and exposure to perchloroethylene in dry-cleaners 1992 ·The Lancet ·Antonio Mutti, Rossella Alinovi, Enrico Bergamaschi, (unknown), Stefania Cavazzini, I Franchini, R. Lauwerys, Alfred Bernard, Harry A. Roels, Ellen Gelpí, J Roselló, Isabel Ramis, Richard Price, Sarah A. Taylor, Marc De Broe, G. Nuyts, (unknown), L. M. Fels, (unknown)	72
16	Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trial. 1991 ·Journal of Clinical Oncology ·Sarah A. Taylor, John Crowley, (unknown), Harmon J. Eyre, (unknown), Harry E. Hynes, (unknown)	20
17	Phase II Trial of Recombinant DNA ?? -Interferon in Advanced Colorectal Cancer: A Southwest Oncology Group Study 1991 ·Journal of Immunotherapy ·Thomas D. Brown, Phyllis J. Goodman, (unknown), John S. Macdonald, (unknown), Sarah A. Taylor, John R. Neefe, Ellen R. Gaynor	4
18	A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study. 1991 ·Journal of Clinical Oncology ·James K. Weick, John Crowley, Ronald B. Natale, Ben Lin Hom, Saul E. Rivkin, (unknown), Sarah A. Taylor, R. B. Livingston	72
19	Phase II trial of echinomycin in advanced soft tissue sarcomas 1990 ·Investigational New Drugs ·Sarah A. Taylor, Barbara Metch, Stanley P. Balcerzak, (unknown)	8
20	Phase II trial of intravenous melphalan for metastatic colorectal carcinoma 1990 ·Investigational New Drugs ·William A. Knight, Phyllis J. Goodman, Sarah A. Taylor, John S. Macdonald, Charles A. Coltman, (unknown), Laurence H. Baker	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact